- Home
- USLM vs ZLAB Comparison
USLM vs ZLAB Comparison
Compare USLM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- ZLAB
- Stock Information
- Founded
- USLM 1948
- ZLAB 2013
- Country
- USLM United States
- ZLAB China
- Employees
- USLM N/A
- ZLAB N/A
- Industry
- USLM Other Metals and Minerals
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- ZLAB Health Care
- Exchange
- USLM Nasdaq
- ZLAB Nasdaq
- Market Cap
- USLM 2.8B
- ZLAB 3.6B
- IPO Year
- USLM N/A
- ZLAB 2017
- Fundamental
- Price
- USLM $104.80
- ZLAB $36.40
- Analyst Decision
- USLM
- ZLAB Buy
- Analyst Count
- USLM 0
- ZLAB 5
- Target Price
- USLM N/A
- ZLAB $54.28
- AVG Volume (30 Days)
- USLM 224.4K
- ZLAB 886.5K
- Earning Date
- USLM 07-30-2025
- ZLAB 08-05-2025
- Dividend Yield
- USLM 0.23%
- ZLAB N/A
- EPS Growth
- USLM 50.52
- ZLAB N/A
- EPS
- USLM 4.20
- ZLAB N/A
- Revenue
- USLM $337,287,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- USLM $21.67
- ZLAB $44.07
- Revenue Next Year
- USLM $13.19
- ZLAB $49.13
- P/E Ratio
- USLM $24.96
- ZLAB N/A
- Revenue Growth
- USLM 17.83
- ZLAB 43.72
- 52 Week Low
- USLM $65.45
- ZLAB $16.01
- 52 Week High
- USLM $159.53
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- USLM 59.04
- ZLAB 52.67
- Support Level
- USLM $96.90
- ZLAB $34.79
- Resistance Level
- USLM $104.56
- ZLAB $36.73
- Average True Range (ATR)
- USLM 3.49
- ZLAB 1.23
- MACD
- USLM 0.41
- ZLAB -0.46
- Stochastic Oscillator
- USLM 97.15
- ZLAB 25.91
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.